[CLS] O
Identification O
of O
APC2 O
, O
a O
homologue O
of O
the O
adenomatous B
polyposis I
coli I
tumour I
suppressor O
. O
[SEP] O

[CLS] O
A O
common O
MSH2 O
mutation O
in O
English O
and O
North O
American O
HNPCC B
families O
: O
origin O
, O
phenotypic O
expression O
, O
and O
sex O
specific O
differences O
in O
colorectal B
cancer I
. O
[SEP] O

[CLS] O
For O
both O
sexes O
combined O
, O
the O
penetrances O
at O
age O
60 O
years O
for O
all O
cancers B
and O
for O
colorectal B
cancer I
were O
0 O
. O
[SEP] O

[CLS] O
Complete B
absence I
of I
C7 I
was O
also O
found O
in O
one O
sibling O
who O
had O
the O
clinical O
syndrome O
of O
meningococcal B
meningitis I
and O
arthritis B
as O
a O
child O
and O
in O
this O
siblings O
clinically O
well O
eight O
- O
year O
- O
old O
son O
. O
[SEP] O

[CLS] O
In O
addition O
, O
a O
significant O
excess O
risk O
of O
basal B
cell I
carcinoma I
was O
seen O
( O
standardized O
incidence O
ratio O
35 O
, O
95 O
% O
confidence O
interval O
7 O
. O
2 O
to O
102 O
) O
. O
[SEP] O

[CLS] O
An O
altered O
beta O
- O
alanine O
, O
uracil O
and O
thymine O
homeostasis O
might O
underlie O
the O
various O
clinical B
abnormalities I
encountered O
in O
patients O
with O
DPD B
deficiency I
. O
[SEP] O

[CLS] O
In O
one O
family O
there O
was O
evidence O
of O
non O
- O
penetrance O
and O
susceptibility O
to O
both O
gastric B
and I
colorectal I
cancer I
; O
thus O
, O
in O
addition O
to O
six O
cases O
of O
gastric B
cancer I
, O
a O
CDH1 O
mutation O
carrier O
developed O
colorectal B
cancer I
at O
age O
30 O
years O
. O
[SEP] O

[CLS] O
We O
report O
that O
heterozygosity O
for O
a O
targeted O
murine O
Wt1 O
allele O
, O
Wt1 O
( O
tmT396 O
) O
, O
which O
truncates O
ZF3 O
at O
codon O
396 O
, O
induces O
mesangial B
sclerosis I
characteristic O
of O
DDS B
in O
adult O
heterozygous O
and O
chimeric O
mice O
. O
[SEP] O

[CLS] O
The O
positive O
control O
for O
DMT1 O
up O
- O
regulation O
was O
a O
murine O
model O
of O
dietary B
iron I
deficiency I
that O
demonstrated O
greatly O
increased O
levels O
of O
duodenal O
DMT1 O
( O
IRE O
) O
mRNA O
. O
[SEP] O

[CLS] O
After O
treatment O
, O
the O
three O
patients O
with O
pure O
spinal B
abnormalities I
showed O
clinical O
and O
neurophysiologic O
worsening O
, O
whereas O
the O
two O
patients O
with O
a O
more O
advanced O
stage O
of O
disease O
( O
exhibited O
by O
SEPs O
) O
showed O
substantially O
unchanged O
clinical O
and O
neurophysiologic O
features O
. O
[SEP] O

[CLS] O
We O
extensively O
analyzed O
genomic O
DNA O
and O
messenger O
RNA O
( O
mRNA O
) O
from O
62 O
unrelated O
Korean O
patients O
with O
familial B
adenomatous I
polyposis I
( O
FAP B
) O
for O
identification O
of O
germline O
adenomatous B
polyposis I
coli I
( O
APC B
) O
gene O
mutations O
. O
[SEP] O

